CI Investments Inc. lowered its stake in shares of Axon Enterprise, Inc (NASDAQ:AXON – Free Report) by 7.4% during the first quarter, HoldingsChannel.com reports. The firm owned 96,293 shares of the biotechnology company’s stock after selling 7,725 shares during the period. CI Investments Inc.’s holdings in Axon Enterprise were worth $40,895,000 at the end of the most recent quarter.
A number of other hedge funds also recently made changes to their positions in AXON. Creative Financial Designs Inc. ADV purchased a new stake in shares of Axon Enterprise during the 4th quarter valued at $28,000. Sound Income Strategies LLC increased its holdings in shares of Axon Enterprise by 550.0% during the 4th quarter. Sound Income Strategies LLC now owns 52 shares of the biotechnology company’s stock worth $30,000 after buying an additional 44 shares during the last quarter. Camelot Portfolios LLC purchased a new position in shares of Axon Enterprise in the 4th quarter worth $30,000. AlphaCentric Advisors LLC purchased a new position in shares of Axon Enterprise in the 4th quarter worth $34,000. Finally, Lodestone Wealth Management LLC acquired a new position in Axon Enterprise in the fourth quarter valued at $35,000. Institutional investors and hedge funds own 79.08% of the company’s stock.
Wall Street Analysts Forecast Growth
A number of equities research analysts have issued reports on AXON shares. JPMorgan Chase & Co. boosted their price target on Axon Enterprise from $750.00 to $755.00 and gave the company an “overweight” rating in a research report on Thursday, May 7th. Morgan Stanley set a $600.00 price objective on Axon Enterprise in a report on Thursday, May 7th. TD Cowen reduced their price objective on Axon Enterprise from $950.00 to $825.00 and set a “buy” rating on the stock in a research note on Wednesday, April 8th. Needham & Company LLC boosted their target price on Axon Enterprise from $600.00 to $750.00 and gave the stock a “buy” rating in a report on Monday, July 6th. Finally, Royal Bank Of Canada reiterated an “outperform” rating on shares of Axon Enterprise in a report on Tuesday. Fifteen research analysts have rated the stock with a Buy rating and three have given a Hold rating to the stock. Based on data from MarketBeat.com, the company presently has a consensus rating of “Moderate Buy” and an average target price of $725.25.
Insider Buying and Selling
In related news, insider Elizabeth Reid Coughlin sold 1,554 shares of the business’s stock in a transaction that occurred on Thursday, June 4th. The stock was sold at an average price of $485.00, for a total transaction of $753,690.00. Following the transaction, the insider directly owned 34,024 shares of the company’s stock, valued at approximately $16,501,640. The trade was a 4.37% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is accessible through the SEC website. Also, CEO Patrick W. Smith sold 10,000 shares of the business’s stock in a transaction that occurred on Tuesday, July 7th. The stock was sold at an average price of $643.79, for a total value of $6,437,900.00. Following the transaction, the chief executive officer directly owned 3,040,997 shares in the company, valued at $1,957,763,458.63. This trade represents a 0.33% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Over the last three months, insiders have sold 58,989 shares of company stock valued at $30,527,983. 4.20% of the stock is owned by insiders.
Axon Enterprise Stock Performance
NASDAQ:AXON opened at $511.17 on Wednesday. The company has a current ratio of 2.27, a quick ratio of 1.93 and a debt-to-equity ratio of 0.49. The firm has a market capitalization of $41.20 billion, a price-to-earnings ratio of 205.29, a PEG ratio of 10.76 and a beta of 1.38. The firm’s fifty day simple moving average is $476.68 and its 200 day simple moving average is $480.47. Axon Enterprise, Inc has a twelve month low of $339.01 and a twelve month high of $885.91.
Axon Enterprise (NASDAQ:AXON – Get Free Report) last announced its quarterly earnings results on Wednesday, May 6th. The biotechnology company reported $1.61 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.60 by $0.01. Axon Enterprise had a return on equity of 3.78% and a net margin of 6.90%.The firm had revenue of $807.35 million during the quarter, compared to the consensus estimate of $778.90 million. During the same period in the prior year, the firm earned $1.47 EPS. The firm’s quarterly revenue was up 33.7% compared to the same quarter last year. As a group, equities research analysts expect that Axon Enterprise, Inc will post 1.63 earnings per share for the current fiscal year.
Axon Enterprise Profile
Axon Enterprise, Inc develops technology and weapons systems for public safety and law enforcement agencies, combining hardware, software and cloud services. The company’s hardware portfolio includes conducted energy weapons (commonly known as TASER devices), body-worn cameras and in-car camera systems. Axon pairs these devices with a suite of connected products and accessories designed to capture, store and manage field evidence.
Beyond hardware, Axon operates a subscription-based software platform for digital evidence management, evidence review and records management.
Recommended Stories
- Five stocks we like better than Axon Enterprise
- Confidence Is Back, But Earnings Show the Consumer Is Being Picky
- AeroVironment’s Stock Is Down, But Drone Demand Is Taking Off
- 3M’s Redemption Arc: Can Q2 Earnings Change the Narrative?
- 3 Photonics Companies Making Quantum Tech Possible
Want to see what other hedge funds are holding AXON? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Axon Enterprise, Inc (NASDAQ:AXON – Free Report).
Receive News & Ratings for Axon Enterprise Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Axon Enterprise and related companies with MarketBeat.com's FREE daily email newsletter.
